Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D'Arena

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Haematologica|July 11, 1998
CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtypeN Cascavilla, P Musto, G D'Arena, et al.
Haematologica|May 1, 1996
Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patientsG D'Arena, N Cascavilla, P Musto, et al.
Haematologica|January 9, 2001
Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin aloneP Musto, G Sanpaolo, G D'Arena, et al.
Leukemia & Lymphoma|May 1, 1996
Are "early" and "late" T-acute lymphoblastic leukemias different diseases? A single center study of 34 patientsN Cascavilla, P Musto, G D'Arena, et al.
Haematologica|November 1, 1994
Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytesP Musto, S Modoni, G Alicino, et al.
American Journal of Hematology|August 6, 1998
Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignanciesG D'Arena, P Musto, L Di Mauro, et al.
Leukemia & Lymphoma|June 28, 2001
Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center studyA M Carella, N Cascavilla, M M Greco, et al.
British Journal of Haematology|May 1, 1995
Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemiaP Musto, C Bodenizza, A Falcone, et al.
Mini Reviews in Medicinal Chemistry|May 13, 2011
Targeting regulatory T cells for anticancer therapyG D'Arena, S Deaglio, L Laurenti, et al.
Mini Reviews in Medicinal Chemistry|May 13, 2011
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemiaL Laurenti, L De Padua, G D'Arena, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Haematologica|July 11, 1998
CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtypeN Cascavilla, P Musto, G D'Arena, et al.
Haematologica|May 1, 1996
Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patientsG D'Arena, N Cascavilla, P Musto, et al.
Haematologica|January 9, 2001
Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin aloneP Musto, G Sanpaolo, G D'Arena, et al.
Leukemia & Lymphoma|May 1, 1996
Are "early" and "late" T-acute lymphoblastic leukemias different diseases? A single center study of 34 patientsN Cascavilla, P Musto, G D'Arena, et al.
Haematologica|November 1, 1994
Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytesP Musto, S Modoni, G Alicino, et al.
American Journal of Hematology|August 6, 1998
Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignanciesG D'Arena, P Musto, L Di Mauro, et al.
Leukemia & Lymphoma|June 28, 2001
Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center studyA M Carella, N Cascavilla, M M Greco, et al.
British Journal of Haematology|May 1, 1995
Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemiaP Musto, C Bodenizza, A Falcone, et al.
Mini Reviews in Medicinal Chemistry|May 13, 2011
Targeting regulatory T cells for anticancer therapyG D'Arena, S Deaglio, L Laurenti, et al.
Mini Reviews in Medicinal Chemistry|May 13, 2011
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemiaL Laurenti, L De Padua, G D'Arena, et al.
Pageof 5